Business Context and Reporting Period
This Form 8-K filing by Moderna, Inc. (MRNA) reports on corporate governance events occurring on May 6, 2026. The filing covers the results of the 2026 Annual Meeting of Stockholders and an immediate amendment to the Company's By-Laws regarding legal forum selection.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Corporate Actions
By-Law Amendment
The Board of Directors approved an amendment to the Second Amended and Restated By-Laws effective immediately. This designates the federal district courts of the United States as the sole and exclusive forum for complaints arising under the Securities Act of 1933, unless the Company consents to an alternative forum.
Annual Meeting Voting Results
- Proposal 1 (Election of Directors): Stockholders elected Sandra Horning, M.D., and Abbas Hussain as Class II directors.
- Sandra Horning, M.D.: 210,914,932 votes For; 49,357,015 votes Against.
- Abbas Hussain: 256,398,374 votes For; 4,015,044 votes Against.
- Proposal 2 (Executive Compensation): Stockholders approved the compensation of named executive officers on a non-binding advisory basis.
- Result: 169,401,841 votes For; 90,761,924 votes Against.
- Proposal 3 (Frequency of Compensation Votes): Stockholders voted to hold future advisory votes on executive compensation annually.
- Result: 259,590,666 votes for 1 year; 113,043 votes for 2 years; 618,688 votes for 3 years.
- Proposal 4 (Auditor Ratification): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2026.
- Result: 298,823,277 votes For; 3,406,479 votes Against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, or specific risk factors beyond the procedural change in the legal forum for securities claims. The By-Law amendment was enacted in response to recent amendments to the General Corporation Law of the State of Delaware.
Key Facts for Investor Verification
- Verify the full text of the By-Law Amendment (Exhibit 3.1) to understand the scope of the exclusive federal forum provision.
- Note the significant number of votes cast against the election of Sandra Horning, M.D. (approx. 49.4 million) compared to other directors.
- Observe the substantial opposition to the executive compensation proposal (approx. 90.8 million votes against), indicating potential shareholder dissatisfaction with pay practices.
- Confirm that the Company has committed to annual advisory votes on executive compensation based on the Proposal 3 results.
